Pavel Iliasov

Dr. Pavel Iliasov


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Russian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
ASA. V. Sokolov
A. V. Sokolov
LLL. V. Limareva
L. V. Limareva
PIPavel Iliasov
Pavel Iliasov
OGO. V. Gribkova
O. V. Gribkova
ASA. S. Sustretov
A. S. Sustretov
The review discusses different methods of encapsulation and biomineralization of macromolecules and living cells. Main advantages and disadvantages of most commonly used carriers, matrices, and materials for immobilization of proteins, enzymes, nucleic acids, and living cells are briefly surveyed. Examples of delivery vehicles for multifunctional encapsulation of protein-like substances are presented. Particular attention is paid to prospects of using metal–organic frameworks in medicine and biotechnology.

11 April 2024 in Vavilov Journal of Genetics and Breeding
Verified
Journal Article
Open access
PDF file
ISI. H. Shaikhutdinov
I. H. Shaikhutdinov
PIPavel Iliasov
Pavel Iliasov
OGO. V. Gribkova
O. V. Gribkova
LLL. V. Limareva
L. V. Limareva
Невирусные системы внутриклеточной доставки инструментов редактирования генома

1 January 2024 in Open Veterinary Journal
Verified
Journal Article
Open access
SESergey Engashev
Sergey Engashev
ASAleksey Savinkov
Aleksey Savinkov
EEEkaterina Engasheva
Ekaterina Engasheva
ALArtyom Lyamin
Artyom Lyamin
DIDanir Ismatullin
Danir Ismatullin
AKAleksandr Komarov
Aleksandr Komarov
Background: Young farm animals are susceptible to the opportunistic infections which may cause economic losses due to mortality and poor weight gain. Development of antimicrobial resistance and desire to improve therapy efficacy and safety are the reasons to seek for new antibacterial drugs ensuring rapid recovery with minimum adverse events. Aim: To estimate the efficacy of DOKSI AVZ 500 in respiratory pathologies in young pigs. Methods: The study was conducted in 65–70-day old Yorkshire piglets with the signs of bacterial respiratory pathologies. The animals were treated with the test drug for 3 or 5 days. The reference group received TETRAMAX 500 which is similar to the test drug in terms of chemical structure, mechanism of action and spectrum. The animal status was assessed using clinical examination, CBC and bacteriological tests. Results: Both test and reference drugs were well tolerated and ensured the animal recovery within about 4 days. The recovery was accompanied with normalization of hematological parameters and flora composition. The bacteria associated with the disease development, Streptococcus suis, was virtually completely eliminated in all groups. No adverse events were noted. After the treatment, all the animals readily gained the weight and live market quality. Conclusion: DOKSI AVZ 500 was a highly efficient therapy for respiratory pathologies caused by the resident opportunistic flora in piglets. It also has shown noninferiority vs. TETRAMAX 500 in terms of all the health-related parameters and thus can be recommended for introduction in veterinary practice in pig farms.